Our Story

LiHe NeoSyn is a crucial component of Lixinghe’s global strategy to promote the integrated development of industry, academia, and research.

We advance steadily, building upon the parent company’s legacy of “Three Generations, One Mission” and its robust technological foundation. This innovative journey began with Professor Jia Ruijin’s pioneering research, was advanced through Mr. Zhang Hejun’s profound clinical practice, and culminated in Ms. Zhang Yanming’s systematic integration and industrial breakthrough.

LiHe NeoSyn is not merely a commercial data analysis window for overseas markets; rather, we are a core R&D and commercial hub for “Technology-Enhanced TCM” going global. We are dedicated to integrating medical wisdom originating from China with cutting-edge technological devices. Through in-depth product localization and continuous innovation, we aim to meet the demand for high-quality medical solutions in North America and the global market. Our business encompasses international technology transfer, localized R&D, market education, brand building, and high-end technical services, aiming to build a vital bridge connecting Chinese and Western medicine and driving transformation in the global health industry.